- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.01. | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.12.25 | Marpai meldet starke Vertriebserfolge für 2026 und verlängert Vereinbarung mit Aetna | 12 | Investing.com Deutsch | ||
| 01.12.25 | Marpai reports strong 2026 sales and renews Aetna network agreement | 6 | Investing.com | ||
| 13.11.25 | Marpai verfehlt Gewinnerwartungen - Aktie bricht um 20 % ein | 2 | Investing.com Deutsch | ||
| MARPAI Aktie jetzt für 0€ handeln | |||||
| 13.11.25 | Marpai GAAP EPS of -$0.20, revenue of $4.03M | 1 | Seeking Alpha | ||
| 12.11.25 | Marpai Reports Third Quarter 2025 Financial Results | 103 | PR Newswire | Continued Turnaround Driven by Cost Discipline and Operational Efficiency; Positioned for Strong 2026 Growth
TAMPA, Fla., Nov. 12, 2025 /PRNewswire/ -- Marpai... ► Artikel lesen | |
| 12.11.25 | Marpai, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.11.25 | Marpai, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 06.10.25 | Marpai receives $200,000 investment from CEO's investment fund | 1 | Investing.com | ||
| 06.10.25 | Marpai raises $200K in private placement with CEO-backed HillCour Investment | 1 | Seeking Alpha | ||
| 06.10.25 | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.09.25 | Marpai, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 29.08.25 | Führungswechsel bei Marpai: Dallas Scrip wird neuer Präsident nach Rücktritt von John Powers | 1 | Investing.com Deutsch | ||
| 27.08.25 | Marpai, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.08.25 | Marpai GAAP EPS of -$0.28, revenue of $4.6M | 1 | Seeking Alpha | ||
| 13.08.25 | Marpai, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.08.25 | Marpai Reports Second Quarter 2025 Financial Results | 379 | PR Newswire | Marpai Slashes Losses by Two-Thirds in Q2 2025, Paving the Way to Profitability.Operating Expenses Cut 70% as Turnaround Gains Traction
TAMPA, Fla., Aug. 13,... ► Artikel lesen | |
| 14.05.25 | Marpai Reports First Quarter 2025 Financial Results | 148 | PR Newswire | Marpai's turnaround momentum is building
TAMPA, Fla., May 14, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative... ► Artikel lesen | |
| 13.05.25 | Marpai Hires Dallas Scrip As Chief Operating Officer | 157 | PR Newswire |
Marpai Bolsters Leadership Team to Drive Profitable High-Growth Strategy with Key Executive Appointment
TAMPA, Fla., May 13, 2025 /PRNewswire/ -- Marpai, Inc.... ► Artikel lesen | |
| 26.03.25 | Marpai Reports Fourth Quarter And Full Year 2024 Financial Results | 172 | PR Newswire | MARPAI EXHIBITS STRONG, ONGOING FINANCIAL IMPROVEMENT
TAMPA, Fla., March 26, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| TELADOC HEALTH | 4,240 | -0,05 % | Teladoc Health, Inc.: Teladoc Health to Announce Fourth Quarter 2025 Financial Results | ||
| NUGEN MEDICAL DEVICES | 0,019 | +7,87 % | NuGen Medical Devices Inc.: NuGen Medical Devices Inc. Provides Update on Health Canada License | Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 02.02.2026 | The following instruments on XETRA do have their first trading 02.02.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.02.2026
Aktien
1 CA00249P1053 AXA S.A. CDR
2 ARP125991090... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,172 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.01.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 22.01.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.01.2026ISIN NameCA74290F1009 PROBE... ► Artikel lesen | |
| MEMPHASYS | 0,003 | -14,29 % | XFRA IG7: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILMEMPHASYS LTD IG7... ► Artikel lesen | |
| LOGICMARK | - | - | LogicMark, Inc. Announces Third Quarter 2025 Results | LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and... ► Artikel lesen | |
| ASSURANCE HEALTHCARE | 0,001 | 0,00 % | ASSURANCE HEALTHCARE LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::HALF YEARLY RESULTS | ||
| INVO FERTILITY | 1,100 | +4,76 % | INVO Fertility, Inc.: INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth | SARASOTA, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | DAX-Konzern Siemens Healthineers legt Zahlen vor | Siemens Healthineers startet solide ins neue Geschäftsjahr und bestätigt den Jahresausblick, wird aber vom schwachen Diagnostikgeschäft in China gebremst. Der DAX-Konzern Siemens Healthineers ist mit... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | ANALYSE-FLASH: Barclays senkt Carl Zeiss Meditec auf 'Equal Weight' | LONDON (dpa-AFX Broker) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen |
MARPAI INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MARPAI INC finden Sie auf Wallstreet Online.